Skip to content
Review Open access

Machine Learning and Deep Learning for the Diagnosis of Cervical Degenerative Diseases: Systematic Review and Meta-Analysis

Oct 2026 · Journal of Medical Internet Research · Vol 28, pp. e92008-e92008 · 0 citations · 81 references
Medicine

TL;DR

This study provides pooled estimates of the diagnostic performance of TML and DL for cervical degenerative diseases and indicates that, given between-study heterogeneity and low certainty of evidence, AI should currently be used as clinical decision support rather than an independent replacement for physicians.

Abstract

Abstract Background Cervical degenerative diseases are a global public health issue, and their incidence is rising worldwide. Although an increasing number of studies on traditional machine learning (TML) and deep learning (DL) have been conducted in the detection and segmentation of cervical degenerative diseases and have reported promising task-specific results, the performance of these models has not yet been systematically analyzed. Objective This systematic review and meta-analysis aimed to summarize and evaluate existing evidence on TML and DL approaches for diagnosing cervical degenerative diseases, thereby comprehensively guiding future research and clinical applications. Methods This systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A comprehensive literature search was conducted on PubMed, Embase, the Cochrane Library, Web of Science, Scopus, and the Institute of Electrical and Electronics Engineers (IEEE Xplore) from January 2000 to June 2026, supplemented by backward and forward citation searching in Scopus. Studies evaluating TML and DL algorithms for diagnosing cervical degenerative diseases using medical imaging were included. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool and the Quality Assessment of Diagnostic Accuracy Studies AI (QUADAS-AI) tool. For the primary diagnostic accuracy meta-analysis, data were synthesized using a bivariate mixed-effects logistic regression model. Sensitivity and specificity were summarized separately using random-effects meta-analysis with the Knapp-Hartung adjustment, and 95% prediction intervals (PIs) were reported. Certainty of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Results This systematic review included 30 studies, of which 21 involved a total of 25,301 patients included in the meta-analysis. The pooled sensitivity and specificity were 0.92 (95% CI 0.89‐0.96; 95% PI 0.80‐1.00) and 0.88 (95% CI 0.84‐0.91; 95% PI 0.72‐1.00), respectively. The positive likelihood ratio (LR) was 8.36 (95% CI 6.14‐11.36), and the negative LR was 0.07 (95% CI 0.04‐0.11). The area under the summary receiver operating characteristic (SROC) curve was 0.96 (95% CI 0.94‐0.97). Leave-one-out analyses did not materially alter the pooled estimates. High risk of bias was identified in 4 studies using QUADAS-2 and in 17 using QUADAS-AI. The overall certainty of evidence was rated as low according to the GRADE approach. Conclusions TML and DL models demonstrated satisfactory diagnostic performance for cervical degenerative diseases, although external validation was limited. Unlike previously published reviews in this field, this study provides pooled estimates of the diagnostic performance of TML and DL for cervical degenerative diseases and indicates that, given between-study heterogeneity and low certainty of evidence, AI should currently be used as clinical decision support rather than an independent replacement for physicians.

Read PDF

Similar papers

Review Open access Aug 2026

Machine learning driven Glioma classification: systematic review, bibliometric insights and semantic exploration of YOLO-based detection frameworks

The Glioma binary classification has become a significant field of research because of its clinical application in the diagnosis and the treatment planning. The recent advances in machine learning (ML) and deep learning (DL) allowed analyzing medical images automatically, specifically magnetic resonance imaging (MRI)....

K. Bhatele, Smriti Rathore, M. Dixit et al. · 0 citations
Review Open access Oct 2026

Accuracy of Machine Learning in Differential Diagnosis of Multiple System Atrophy: A Systematic Review and Meta-Analysis.

BACKGROUND Multiple system atrophy (MSA) is frequently misdiagnosed as Parkinson's disease (PD) or progressive supranuclear palsy (PSP), posing significant diagnostic challenges. OBJECTIVE The aim of the study was to systematically evaluate the efficacy of machine learning (ML) in differentiating MSA from other neuro...

Gui-Sheng Wang, Chao Nie, Mei-Chen Liu · 0 citations
Review Open access Sep 2026

Deep Learning and Machine Learning Algorithms for Cervical Cancer Segmentation on MRI: A Systematic Review

ABSTRACT Introduction Cervical cancer management relies heavily on magnetic resonance imaging (MRI) for staging and treatment planning; however, manual segmentation is time‐consuming and prone to variability. This systematic review aimed to evaluate the performance and clinical potential of machine learning (ML) and de...

Somayeh Haji Ahmadi, Sina Soltan Mohammadi, Abolfazl Koozari et al. · 0 citations
Review Oct 2026

Artificial Intelligence Techniques for Diagnosing and Quantifying Vitiligo: A Systematic Review and Meta-Analysis.

The utilization of machine learning (ML) and deep learning (DL) for vitiligo, particularly in image and object recognition, allows for the creation of innovative techniques that may match the precision and accuracy of current clinical methodologies. This systematic review seeks to explore how imaging-based artificial i...

N. Ede, Fatima Khan, Imelda L. Vetter et al. · 0 citations
Review Open access Sep 2026

ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW

Artificial intelligence algorithms exhibit robust diagnostic accuracy for csPCa detection, matching expert clinicians and offering significant potential to standardize prostate cancer care to establish long-term clinical utility.

Anjas Anhar Prastowo, M. Ali · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.